Centre for Health Informatics, Australian Institute of Health Innovation, University of New South Wales, Sydney 2052, Australia.
BMC Health Serv Res. 2013 Oct 14;13:414. doi: 10.1186/1472-6963-13-414.
Severe hypertension (SHT) (Blood Pressure, BP ≥ 180/110 mmHg) is associated with considerable morbidity and mortality, yet little is known about how it is managed. The purpose of this study is to examine the management of SHT by Australian general practitioners (GPs) and to explore its variance across patient characteristics and clinical practices.
Review of electronic medical records for a year before and after a recorded measure of SHT in 7,499 patients by 436 GPs in 167 clinics throughout Australia during 2008-2009. Outcome measures included follow-up, referral, changes to antihypertensive drug treatment, and BP control (normotensive reading, BP < 140/90 mmHg, and whether subsequent recorded measures were also in the normal range--sustained normotension).
Of 7,499 patients with an electronic BP record of SHT, 94% were followed up (median time 14 days); 8% were referred to an appropriate specialist (median time 89 days--2% within 7 days) and 86% were managed by GPs. GPs initiated or changed antihypertensive drugs in 5,398 patients (72% of cohort); of these, 46% remained hypertensive (4% with SHT) and 7% achieved sustained normotension; 6% had no further electronic BP records. The remaining 14% had no medication changes; among these, 43% remained hypertensive (5% with SHT) and 3% achieved sustained normotension; 32% had no further electronic BP records. Some outcome measures displayed a variance across GP clinics that was mostly unexplained by patient or practice characteristics.
Most patients with SHT had at least one follow-up visit and 72% had initiation of, or changes to, antihypertensive drug treatment. Although most of the patients experienced some improvement, blood pressure control was poor. Some clinics showed better performance. Suggestions are made for the development of clinical standards to facilitate appropriate management of this dangerous condition.
重度高血压(SHT)(血压≥180/110mmHg)与相当大的发病率和死亡率有关,但对于其管理方法知之甚少。本研究的目的是检查澳大利亚全科医生(GP)对 SHT 的管理,并探讨其在患者特征和临床实践中的差异。
在 2008-2009 年期间,通过澳大利亚 167 家诊所的 436 名 GP 对 7499 名患者进行了一次记录 SHT 前后一年的电子病历回顾。结果测量包括随访、转诊、抗高血压药物治疗的改变以及血压控制(正常读数,BP<140/90mmHg,以及随后的记录测量是否也在正常范围内——持续正常血压)。
在有电子血压记录 SHT 的 7499 名患者中,94%得到了随访(中位数时间为 14 天);8%被转介给适当的专科医生(中位数时间为 89 天-2%在 7 天内),86%由 GP 管理。GP 在 5398 名患者中启动或改变了抗高血压药物(队列的 72%);其中,46%仍然患有高血压(4%患有 SHT),7%实现了持续正常血压;6%没有进一步的电子血压记录。其余 14%没有改变药物治疗;其中,43%仍然患有高血压(5%患有 SHT),3%实现了持续正常血压;32%没有进一步的电子血压记录。一些结果测量在 GP 诊所之间存在差异,这些差异主要无法用患者或实践特征来解释。
大多数 SHT 患者至少有一次随访,72%的患者开始或改变了抗高血压药物治疗。尽管大多数患者有所改善,但血压控制仍不理想。一些诊所表现更好。为制定临床标准以促进对这种危险疾病的适当管理提出了建议。